Transenterix

Shares of TransEnterix Inc (NYSE: TRXC), a medical device company that focuses on the development of a robotic assisted surgical system called SurgiBot System, plunged 50 percent on Thursday. TransEnterix announced that the U.S. Food and Drug Administration (FDA) notified the company on April 17...

Shares of Transenterix Inc (NYSE: TRXC) were highly volatile on Monday after the company received an update from the U.S. Food and Drug Administration. Transenterix applied for a 510(k) submission with the FDA, which would grant the company marketing clearance for its SurgiBot, a robotically...

Shares of Transenterix Inc (NYSE: TRXC) hit an intra-day low of $3.30 on Friday, but quickly rebounded to trade nearly flat on the day following a report by The Street Sweeper. According to The Street Sweeper's Sonya Colberg, TransEnterix investors should "consider running away,...

Shares of Transenterix Inc (NYSE: TRXC), a medical device company that focuses on robotic assisted surgery, were trading lower by around 15 percent early Wednesday morning after the company announced on Tuesday it plans to offer and sell up to $43.56 million of its common stock. Transenterix...

Shares of Transenterix Inc (NYSE: TRXC), a medical device company focused on the development and commercialization of a robotic assisted surgical system, were trading higher by more than 30 percent on Wednesday on no confirmed news. Investors and traders may have been speculating that...